Literature DB >> 18594467

First report of ovarian dysgerminoma in Cowden syndrome with germline PTEN mutation and PTEN-related 10q loss of tumor heterozygosity.

Mee-Yon Cho1, Hyun Soo Kim, Charis Eng, Dae Sung Kim, Seong Joon Kang, Minseob Eom, Sang Yeop Yi, Mary P Bronner.   

Abstract

We present the first report of ovarian dysgerminoma in Cowden syndrome, presenting in a 7-year-old girl. In her second decade, a hamartomatous soft tissue extremity mass and diffuse gastrointestinal hamartomatous polyposis with pathologic features suggestive of either juvenile, Peutz-Jeghers, or Cowden polyps were identified, along with diffuse esophageal glycogenic acanthosis and skin manifestations. During regular thyroid cancer surveillance under the provisional diagnosis of Cowden syndrome, papillary thyroid carcinoma and benign follicular nodules were diagnosed at age 23. PTEN mutational analysis revealed a novel germline nonsense point mutation of Q219X. Loss of PTEN heterozygosity was also present in the ovarian dysgerminoma. Parental mutation testing and phenotype screening were negative. The correct classification of Cowden syndrome is difficult because of its protean manifestations and overlapping phenotypes with other genetic and noninherited pathologies, particularly regarding various gastrointestinal polyposis syndromes. Despite the challenges, correct classification is critical to patient care because of the associated cancer predispositions and necessary surveillance programs. This is the first report of Cowden syndrome presenting with ovarian dysgerminoma, which implicates PTEN in the molecular pathogenesis of dysgerminoma and adds it to the phenotypic manifestations of Cowden syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18594467     DOI: 10.1097/PAS.0b013e31816be8b7

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

1.  Aloe-emodin suppresses esophageal cancer cell TE1 proliferation by inhibiting AKT and ERK phosphorylation.

Authors:  Xiaobin Chang; Jimin Zhao; Fang Tian; Yanan Jiang; Jing Lu; Junfen Ma; Xiaoyan Zhang; Guoguo Jin; Youtian Huang; Zigang Dong; Kangdong Liu; Ziming Dong
Journal:  Oncol Lett       Date:  2016-07-25       Impact factor: 2.967

2.  Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations.

Authors:  Scott K Sherman; Jessica E Maxwell; Qining Qian; Andrew M Bellizzi; Terry A Braun; Mark D Iannettoni; Benjamin W Darbro; James R Howe
Journal:  Cancer Genet       Date:  2014-11-15

Review 3.  Hereditary breast and ovarian cancer: new genes in confined pathways.

Authors:  Finn Cilius Nielsen; Thomas van Overeem Hansen; Claus Storgaard Sørensen
Journal:  Nat Rev Cancer       Date:  2016-08-12       Impact factor: 60.716

4.  A Case Report of Syndromic Multinodular Goitre in Adolescence: Exploring the Phenotype Overlap between Cowden and DICER1 Syndromes.

Authors:  Dorothée Bouron-Dal Soglio; Leanne de Kock; Richard Gauci; Nelly Sabbaghian; Elizabeth Thomas; Helen C Atkinson; Nicholas Pachter; Simon Ryan; John P Walsh; M Priyanthi Kumarasinghe; Karen Carpenter; Ayça Aydoğan; Colin J R Stewart; William D Foulkes; Catherine S Choong
Journal:  Eur Thyroid J       Date:  2017-11-21

5.  Multiple primary malignancies and subtle mucocutaneous lesions associated with a novel PTEN gene mutation in a patient with Cowden syndrome: case report.

Authors:  Peter Vasovčák; Mária Senkeříková; Jana Hatlová; Anna Křepelová
Journal:  BMC Med Genet       Date:  2011-03-15       Impact factor: 2.103

Review 6.  Genetic basis of Cowden syndrome and its implications for clinical practice and risk management.

Authors:  Amanda Gammon; Kory Jasperson; Marjan Champine
Journal:  Appl Clin Genet       Date:  2016-07-13

7.  Metachronous ovarian endometrioid carcinomas in a patient with a PTEN variant: case report of incidentally detected Cowden syndrome.

Authors:  Hiroyuki Matsubayashi; Satomi Higashigawa; Yoshimi Kiyozumi; Yasue Horiuchi; Yasuyuki Hirashima; Nobuhiro Kado; Masato Abe; Takuma Ohishi; Sumiko Ohnami; Kenichi Urakami; Ken Yamaguchi
Journal:  BMC Cancer       Date:  2019-10-29       Impact factor: 4.430

Review 8.  Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?

Authors:  Davide Angeli; Samanta Salvi; Gianluca Tedaldi
Journal:  Int J Mol Sci       Date:  2020-02-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.